INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT
Talk to us

Testimonial: “Thanks to Indero’s adaptive approach, we sailed through our trial with ease!”

Indero

Indero

Team of Experts

Author picture

Innovaderm is proud of its partnership with BioMimetix JV, LLC.

Read what their Clinical Operation Director has to share on our expertise:

“Our collaboration with Innovaderm has been truly outstanding. We initially sought their expertise in an atopic dermatitis trial management and right from the start, the team impressed us with their proficiency and professionalism. Their PM, CTM, and the entire team exhibited a deep understanding of dermatology trials. They were quick to recognize our unique needs and worked diligently to address them. The team was not only knowledgeable but also innovative, suggesting effective approaches to optimize resources and streamline processes. Their flexibility and willingness to adapt were invaluable, enabling us to navigate challenges and pivot when necessary. Innovaderm has proven to be a reliable and invaluable partner, and we look forward to continuing our successful collaboration with them.”

Sara Penchev, Director of Clinical Operations, BioMimetix JV, LLC

Need help with your next dermatology or rheumatology study? Tell us a little about your needs.

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.
Talk to us

Jeff Smith

Chef de la direction
Linkedin

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.
LEARN MORE >